# Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment

> **NCT04613167** · NA · UNKNOWN · sponsor: **University Medical Centre Ljubljana** · enrollment: 70 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Premature Coronary Heart Disease
- Lipoproteinemia
- Inflammation
- Genetic Polymorphisms

## Interventions

- **DRUG:** Alirocumab
- **DRUG:** Evolocumab
- **DRUG:** Control group

## Key facts

- **NCT ID:** NCT04613167
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-10
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-10-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04613167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04613167, "Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04613167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*